Vincerx Pharma Inc.
13F holders, Q4 2024 (December 31)20holders −6
1new positions
7sold out
1famous investor
$0.26avg. 13F price*
At the end of Q4 2024, 20 institutions reported holding Vincerx Pharma Inc. in their 13F filings, down 6 from Q3 2024. 1 opened new positions and 7 sold out. The largest holders were Sage Rhino Capital LLC ($448K), Rock Springs Capital Management LP ($234K) and Goldman Sachs Group Inc. ($166K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Vincerx Pharma Inc.
- CUSIP
- 92731L106
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $3K |
| Exits | 7 | $2.7M |
All 13F filers, Q3 2024 → Q4 2024: 148,910 shares bought and 6,367,446 shares sold, net −6,218,536 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Sage Rhino Capital LLC | 0.10% | No change | 1,703,413 | $448K |
| Rock Springs Capital Management LP | 0.01% | No change | 891,719 | $234K |
| Goldman Sachs Group Inc. | 0.00% | Reduce 0.0% | 631,397 | $166K |
| Armistice Capital, LLC | 0.00% | Reduce -79.0% | 567,011 | $149K |
| Vanguard Group Inc. | 0.00% | Reduce -54.4% | 286,372 | $75K |
| Geode Capital Management, LLC | 0.00% | Reduce -3.7% | 241,517 | $63K |
| Rubric Capital Management LP | 0.00% | No change | 116,873 | $31K |
| UBS Group AG | 0.00% | Add +38882.8% | 92,779 | $24K |
| HRT Financial LP | 0.00% | Add +306.8% | 59,804 | $15K |
| State Street Corp. | 0.00% | No change | 57,016 | $15K |
| BlackRock, Inc. | 0.00% | No change | 47,080 | $12K |
| Northern Trust Corp. | 0.00% | No change | 34,297 | $9K |
| Renaissance Technologies | 0.00% | Reduce -66.5% | 22,100 | $6K |
| Susquehanna International Group, LLP | 0.00% | Reduce -33.2% | 21,371 | $6K |
| Jane Street Group, LLC | 0.00% | Reduce -46.5% | 11,190 | $3K |
| Focus Partners Wealth | 0.00% | New | 10,900 | $3K |
| Morgan Stanley | 0.00% | Add +19.4% | 2,090 | $549 |
| Bank & Trust Co | 0.00% | No change | 1,000 | $263 |
| Bank of America Corp. | 0.00% | Add +12.3% | 237 | $62 |
| JPMorgan Chase & Co. | 0.00% | Reduce -60.3% | 23 | $6 |
"% of holder's portfolio" is VINCERX PHARMA INC's weight in each manager's 13F, not the share of Vincerx Pharma Inc. the manager owns.